KHK6640

DRUG3 trials

Sponsors

Kyowa Kirin Co., Ltd.

Conditions

Alzheimer DiseaseAlzheimer's Disease

Phase 1

A Study of Single and Multiple Doses of KHK6640 in Subjects With Prodromal or Mild to Moderate Alzheimer's Disease

CompletedNCT02127476

Kyowa Kirin Co., Ltd.Alzheimer's Disease

Start: 2014-07-31End: 2017-05-31Updated: 2024-06-17

A Single Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease.

CompletedNCT02377713

Kyowa Kirin Co., Ltd.Alzheimer's Disease

Start: 2015-03-31End: 2016-09-30Updated: 2016-12-07

A Repeated Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease

CompletedNCT03093519

Kyowa Kirin Co., Ltd.Alzheimer Disease

Start: 2017-03-03End: 2017-12-06Updated: 2018-03-20